About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
TsilTg(Myc)12ALvn
transgene insertion 12A, Agnes Lavenu
MGI:2447997
Summary 2 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
hm1
TsilTg(Myc)12ALvn/TsilTg(Myc)12ALvn involves: C57BL/6 * SJL/J MGI:2655289
ht2
TsilTg(Myc)12ALvn/Tsil+ involves: C57BL/6 * SJL/J MGI:2655290


Genotype
MGI:2655289
hm1
Allelic
Composition
TsilTg(Myc)12ALvn/TsilTg(Myc)12ALvn
Genetic
Background
involves: C57BL/6 * SJL/J
Find Mice Using the International Mouse Strain Resource (IMSR)
No mouse lines available in IMSR.
See publication links below for author information.
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• morbidity observed as soon as 1 month of age with death between 2 and 4 months of age

immune system
• increased thymic CD4+ CD8+ population, however mice became moribound and died prior to tumor development

hematopoietic system
• increased thymic CD4+ CD8+ population, however mice became moribound and died prior to tumor development




Genotype
MGI:2655290
ht2
Allelic
Composition
TsilTg(Myc)12ALvn/Tsil+
Genetic
Background
involves: C57BL/6 * SJL/J
Find Mice Using the International Mouse Strain Resource (IMSR)
No mouse lines available in IMSR.
See publication links below for author information.
phenotype observed in females
phenotype observed in males
N normal phenotype
neoplasm
• approximately 50% develop T cell lymphoma between 2 and 5 months of age





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
05/07/2024
MGI 6.23
The Jackson Laboratory